ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., 08594 Seoul, Korea.
School of Chemical and Biological Engineering, Seoul National University, 08826 Seoul, Korea.
Cells. 2020 May 7;9(5):1157. doi: 10.3390/cells9051157.
Exosomes are nano-sized vesicles that serve as mediators for cell-to-cell communication. With their unique nucleic acids, proteins, and lipids cargo compositions that reflect the characteristics of producer cells, exosomes can be utilized as cell-free therapeutics. Among exosomes derived from various cellular origins, mesenchymal stem cell-derived exosomes (MSC-exosomes) have gained great attention due to their immunomodulatory and regenerative functions. Indeed, many studies have shown anti-inflammatory, anti-aging and wound healing effects of MSC-exosomes in various in vitro and in vivo models. In addition, recent advances in the field of exosome biology have enabled development of specific guidelines and quality control methods, which will ultimately lead to clinical application of exosomes. This review highlights recent studies that investigate therapeutic potential of MSC-exosomes and relevant mode of actions for skin diseases, as well as quality control measures required for development of exosome-derived therapeutics.
外泌体是纳米大小的囊泡,可作为细胞间通讯的介质。由于其独特的核酸、蛋白质和脂质货物组成反映了产生细胞的特征,因此外泌体可用作无细胞治疗方法。在各种细胞来源的外泌体中,间充质干细胞衍生的外泌体(MSC-exosomes)因其具有免疫调节和再生功能而备受关注。事实上,许多研究表明 MSC-exosomes 在各种体外和体内模型中具有抗炎、抗衰老和伤口愈合作用。此外,外泌体生物学领域的最新进展使得能够制定特定的指南和质量控制方法,最终将导致外泌体的临床应用。本综述强调了最近研究 MSC-exosomes 的治疗潜力以及与皮肤疾病相关的作用模式,以及外泌体衍生治疗药物开发所需的质量控制措施。